In plain words
In one trial, people swallowed glutathione for six months, and a blood marker of oxidative stress improved. In another trial, people took it for four weeks, and oxidative stress markers in urine did not change. The two trials measured different things over different lengths of time.
The short answer
Two of the three sources are randomized trials on this question, and they point opposite ways. At Penn State, 54 people took 250 or 1,000 mg a day for 6 months. At both doses, the ratio of oxidized to reduced glutathione in whole blood fell, and the authors read this as lower oxidative stress. At Bastyr University, 40 healthy adults took 500 mg twice a day or a placebo for 4 weeks, and their oxidative stress biomarkers did not change. Certainty is low because each result comes from one small trial, and the two trials differ in marker and duration.
Where the evidence sits
Oxidative stress marker fell
No change
■ measured by the source's own study · ◪ pooled analysis, may overlap studies counted here · □ reported, reviewed or argued, no new data
Who says what
| Source | Finding | Design | People | Dose and length | Funding and independence |
|---|---|---|---|---|---|
| Richie et al., 2014 | Lower oxidized-to-reduced glutathione ratio in whole blood at both doses | Randomized controlled trial | 54 | 250 or 1,000 mg a day for 6 months | Not in ledger |
| Allen & Bradley, 2011 | No change in oxidative stress biomarkers | Randomized, placebo-controlled | 40 healthy adults | 500 mg twice a day for 4 weeks | Not in ledger |
| Masterjohn, 2017 | No known adverse effects | Practitioner commentary reporting a supplement study | Not in ledger | 1 g a day for six months | Not in ledger |
Lower oxidized-to-reduced glutathione ratio in whole blood at both doses
No change in oxidative stress biomarkers
No known adverse effects
What did the six-month trial find?
Richie and colleagues at Penn State (2014) gave 54 people 250 mg or 1,000 mg of oral glutathione a day for six months. They measured the ratio of oxidized to reduced glutathione in whole blood:
A reduction in oxidative stress in both GSH dose groups was indicated by decreases in the oxidized to reduced glutathione ratio in whole blood after 6 months.
Terms: GSH is glutathione. The oxidized form is glutathione that has already been used up. The reduced form is still available to the cell.
What did the four-week trial find?
Allen and Bradley at Bastyr University (2011) gave 40 healthy adults 500 mg twice a day or a placebo for four weeks. The ledger records their oxidative stress markers as urinary. The authors wrote:
No significant changes were observed in biomarkers of oxidative stress, including glutathione status, in this clinical trial of oral glutathione supplementation in healthy adults.
Were the two trials measuring the same thing?
The Bastyr markers came from urine, and the Penn State ratio came from whole blood. The Bastyr group took 1,000 mg a day in two doses for four weeks. The Penn State groups took either 250 or 1,000 mg a day for six months. The ledger has no Penn State reading of this ratio at four weeks, so the two trials cannot be lined up at the same time point.
Were side effects reported?
Chris Masterjohn (2017), a practitioner writing on his own site, describes a supplement study at the same dose and length as the Penn State high-dose group. The ledger has no n for the study he cites, and he appears to describe the same trial:
1 gram per day of glutathione for six months has produced no known adverse effects
Why the sources disagree
The two trials differ on four axes. The first is the marker: Bastyr looked at urinary biomarkers, and Penn State looked at a glutathione ratio in whole blood. The second is duration, four weeks against six months. The third is dose: the Penn State result appeared at 250 mg a day as well as at 1,000 mg. The fourth is the comparison. The Bastyr finding is stated against placebo, while the Penn State ratio result in the ledger is stated as a decrease after six months. Both trials are small, at 40 and 54 people. The ledger has no funding details for either. Masterjohn reports a study and adds no new measurement.
What would settle it
An independent placebo-controlled trial of oral glutathione at 1,000 mg a day for six months. It would measure both urinary oxidative stress biomarkers and the whole-blood oxidized-to-reduced glutathione ratio at four weeks, three months and six months, with a pre-registered analysis. A matching result from a second research group would raise certainty from low to moderate.
How this page was made
The 3 sources are the two randomized trials on this question, found through a citation check of PubMed records, and one practitioner commentary. Studies of precursors (cysteine, glycine or NAC), animal studies and drug-delivery studies were left out. Trials of sublingual and liposomal glutathione are recorded under separate subjects. Every claim was copied word for word from its source into the Longevity Circle ledger and checked against the original text. A person approved each claim. "Contested" means independent studies point in both directions, and certainty follows the GRADE levels used in medical reviews. Drafting was assisted by AI.
The ledger holds only 2 studies on this question.
Changelog: 23 Sep 2026, first version, 3 sources.
